Structural and Functional Characteristics of the B-domain-deleted Recombinant Factor VIII Protein, r-VIII SQ
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Summary: Recombinant factor VIII SQ (r-VIII SQ), ReFacto®, is a recombinant factor VIII product similar to the smallest active factor VIII protein found in plasma-derived factor VIII (p-VIII) concentrates. The protein comprises two polypeptide chains of 80 and 90 kDa and lacks the major part of the heavily glycosylated B-domain i.e. amino acids Gln744 to Ser1637. r-VIII SQ retains six potential glycosylation sites for N-linked oligosaccharides at asparagine residues 41, 239, 582, 1685, 1810 and 2118. We describe a thorough comparison of the characteristics of r-VIII SQ with those of p-VIII. The primary and secondary structures of r-VIII SQ were in good agreement with that of B-domain-deleted p-VIII (p-VIII-LMW) as shown by SDS-PAGE, Western blotting with antifactor VIII antibodies, tryptic mapping, amino acid sequence analysis and circular dichroism spectroscopy. A few divergences also existed. Thus r-VIII SQ was shown to contain a small amount of the single chain primary translation product of 170 kDa and also the product specific sequence of 14 amino acids, the SQ-link, in the C-terminal end of the 90 kDa chain. It was shown that r-VIII SQ had a high specific activity of about 14,000 IU VIII:C/mg as determined by use of a chromogenic substrate assay. The r-VIII SQ protein was comparable to p-VIII forms with a retained B-domain, in terms of potency measured by a chromogenic substrate or a two-stage clotting assay, in interactions with thrombin, and with activated protein C (APC) in combination with Protein S. The ability of r-VIII SQ to participate as a cofactor in factor Xa generation in a mixture of factors IXa and X, phospholipid and calcium was in conformity with that of p-VIII. Furthermore r-VIII SQ had a good binding capacity for phospholipid vesicles and von Willebrand factor (vWF) as shown in gel filtration studies. The same kinetics in binding to von Willebrand factor was found for r-VIII SQ and p-VIII as determined by real-time biospecific interaction analysis (BIA) with use of the BIAcore® instrument. The apparent association rate constant was 4 × 106 M−1s−1. Two dissociation rate constants were found, 1 × 10−2s−1 and 4 × 10−4s−1. The results extend the present knowledge that the factor VIII B-domain is dispensable for the factor VIII cofactor function in hemostasis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
[11] Calculation of protein conformation from circular dichroism
Yang, J. T., Wu, C.-S. C., & Martinez, H. M. (1986) · Methods in Enzymology · doi:10.1016/0076-6879(86)30013-2 · Cited by 1,635
Karlsson, R., Michaelsson, A., & Mattsson, L. (1991) · Journal of Immunological Methods · doi:10.1016/0022-1759(91)90331-9 · Cited by 1,077
Molecular cloning of a cDNA encoding human antihaemophilic factor
Toole, J. J., Knopf, J. L., Wozney, J. M., Sultzman, L. A., Buecker, J. L., Pittman, D. D., Kaufman, R. J., Brown, E., Shoemaker, C., Orr, E. C., et al. (1984) · Nature · doi:10.1038/312342a0 · Cited by 925
Structure of human factor VIII
Vehar, G. A., Keyt, B., Eaton, D., Rodriguez, H., O'Brien, D. P., Rotblat, F., Oppermann, H., Keck, R., Wood, W. I., Harkins, R. N., et al. (1984) · Nature · doi:10.1038/312337a0 · Cited by 883
Toole, J. J., Pittman, D. D., Orr, E. C., Murtha, P., Wasley, L. C., & Kaufman, R. J. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.16.5939 · Cited by 311
Biochemical, immunological, and in vivo functional characterization of B-domain-deleted factor VIII
Pittman, D., Alderman, E., Tomkinson, K., Wang, J., Giles, A., & Kaufman, R. (1993) · Blood · doi:10.1182/blood.v81.11.2925.2925 · Cited by 268 · cited 2×
“Thus single gene cDNA constructs encoding for B-domaindeleted factor VIII reported previously have been shown to generate single chain peptides of 120 and 165 kDa (7) and 170 kDa (8) as the prominent species which have no counterpart in p-VIII concentrates.”
BackgroundResultFoster, P., Fulcher, C., Houghten, R., & Zimmerman, T. (1990) · Blood · doi:10.1182/blood.v75.10.1999.1999 · Cited by 189
RAPAPORT, S. I., SCHIFFMAN, S., PATCH, M. J., & AMES, S. B. (1963) · Blood · doi:10.1182/blood.v21.2.221.221 · Cited by 189
A role for the C2 domain of factor VIII in binding to von Willebrand factor
Saenko, E. L., Shima, M., Rajalakshmi, K. J., & Scandella, D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)78167-8 · Cited by 178
Brinkhous, K. M., Sandberg, H., Garris, J. B., Mattsson, C., Palm, M., Griggs, T., & Read, M. S. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.24.8752 · Cited by 172
Self-citation
Cited by
Current clinical applications of in vivo gene therapy with AAVs
Mendell, J. R., Al-Zaidy, S. A., Rodino-Klapac, L. R., Goodspeed, K., Gray, S. J., Kay, C. N., Boye, S. L., Boye, S. E., George, L. A., Salabarria, S., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2020.12.007 · Cited by 743
Survey of the year 2003 commercial optical biosensor literature
Rich, R. L., & Myszka, D. G. (2005) · Journal of Molecular Recognition · doi:10.1002/jmr.726 · Cited by 505
McIntosh, J., Lenting, P. J., Rosales, C., Lee, D., Rabbanian, S., Raj, D., Patel, N., Tuddenham, E. G. D., Christophe, O. D., McVey, J. H., et al. (2013) · Blood · doi:10.1182/blood-2012-10-462200 · Cited by 278
“%) than in animals transduced with the rAAV5-LP1-BDD-hFVIII.6,9 Significantly higher levels (P 5 .0003, 1-way analysis of variance [ANOVA]) of hFVIII:Ag were observed in mice transduced with rAAV5-LP1-codop-hFVIII-N6 and rAAV5-HLP-codop-hFVIII-N6 at 19 6 6% and 22 6 6%, respectively.”
BackgroundMethodInfluentialRational design of a fully active, long-acting PEGylated factor VIII for hemophilia A treatment
Mei, B., Pan, C., Jiang, H., Tjandra, H., Strauss, J., Chen, Y., Liu, T., Zhang, X., Severs, J., Newgren, J., et al. (2010) · Blood · doi:10.1182/blood-2009-11-254755 · Cited by 229
Bioengineering of coagulation factor VIII for improved secretion
Miao, H. Z., Sirachainan, N., Palmer, L., Kucab, P., Cunningham, M. A., Kaufman, R. J., & Pipe, S. W. (2004) · Blood · doi:10.1182/blood-2003-10-3591 · Cited by 210
Metadata
- Authors
- Almstedt, A., Brandt, J., Gray, E., Holmquist, L., Oswaldsson, U., Sebring, S., Mikaelsson, M., & Sandberg, H.
- Corresponding author
- Sandberg, Helena
- Venue
- Thrombosis and Haemostasis
- Publisher
- Georg Thieme Verlag KG
- Published
- 2001
- Volume
- 85
- Issue
- 01
- Pages
- 93-100
- ISSN
- 0340-6245 (ISSN-L)
- 2567-689X
- OpenAlex
- W1923501574
- Cited by
- 85
- References
- 28
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 1 · 2022: 5 · 2021: 2 · 2020: 1 · 2019: 1 · 2018: 4 · 2017: 3 · 2016: 3 · 2015: 1 · 2014: 4 · 2013: 7 · 2012: 6
- FWCI
- 3.54
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Thrombosis and Haemostasis (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Hemophilia Treatment and Research
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein purification and stability
- Keywords
- B-domain deletion, plasma-derived factor VIII, N-glycosylation sites, von Willebrand factor binding, factor Xa generation, activated protein C, thrombin binding
- MeSH terms
- Binding Sites, Blood Coagulation Tests, Circular Dichroism, Factor VIII, Humans, Kinetics, Peptide Fragments, Protein Binding, Recombinant Proteins, von Willebrand Factor, Blotting, Western, Factor Xa, Protein Structure, Secondary, Protein Structure, Tertiary, Surface Plasmon Resonance, Sequence Analysis, Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Structural and Functional Characteristics of the B-domain-deleted Recombinant Factor VIII Protein, r-VIII SQ. https://app.cochat.ai/papers/10.1055/s-0037-1612910
- The paper
- Almstedt, A., Brandt, J., Gray, E., Holmquist, L., Oswaldsson, U., Sebring, S., Mikaelsson, M., & Sandberg, H. (2001). Structural and Functional Characteristics of the B-domain-deleted Recombinant Factor VIII Protein, r-VIII SQ. Thrombosis and Haemostasis. https://doi.org/10.1055/s-0037-1612910
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.